Eli Lilly’s $6 Billion Huntsville Plant: 450 High‑Paying Jobs, GLP‑1 Drug Boom and Alabama’s Biggest Industrial Bet
Eli Lilly will invest over $6 billion to build a pharmaceutical manufacturing campus in Huntsville, Alabama, creating 450 permanent and 3,000 construction jobs. The 260-acre facility will produce active ingredients for small-molecule and peptide medicines, including the oral GLP-1 obesity drug orforglipron. Construction is set to begin in 2026 and finish by 2032. State officials call it Alabama’s largest-ever private industrial investment.